April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Elevated levels of Th17-relevant cytokines in vitreous humor of patients with proliferative diabetic retinopathy
Author Affiliations & Notes
  • Masaru Takeuchi
    Ophthalmology, National Defense Medical College, Tokorozawa, Japan
  • Tomohito Sato
    Ophthalmology, National Defense Medical College, Tokorozawa, Japan
  • Atsushi Tanaka
    Ophthalmology, National Defense Medical College, Tokorozawa, Japan
  • Yoko Karasawa
    Ophthalmology, National Defense Medical College, Tokorozawa, Japan
  • Kohzou Harimoto
    Ophthalmology, National Defense Medical College, Tokorozawa, Japan
  • Yutaka Sakurai
    Ophthalmology, National Defense Medical College, Tokorozawa, Japan
  • Masataka Ito
    Developmental Anatomy, National Defense Medical College, Tokorozawa, Japan
  • Footnotes
    Commercial Relationships Masaru Takeuchi, None; Tomohito Sato, None; Atsushi Tanaka, None; Yoko Karasawa, None; Kohzou Harimoto, None; Yutaka Sakurai, None; Masataka Ito, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1872. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Masaru Takeuchi, Tomohito Sato, Atsushi Tanaka, Yoko Karasawa, Kohzou Harimoto, Yutaka Sakurai, Masataka Ito; Elevated levels of Th17-relevant cytokines in vitreous humor of patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1872. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Elevated levels of inflammatory cytokines and angiogenic factors are known in the vitreous of proliferative diabetic retinopathy (PDR). Recently, increase of circulating Th17 cells and elevated activation of Th17 signature genes have been reported in type 2 diabetic patients as well as the involvement of Th17 cells in development of type 1 diabetes. The study was conducted to investigate Th17-mediated immune responses involved in PDR by analysis of cytokine levels in the vitreous.

Methods: Vitreous samples were collected from 9 eyes with epiretinal membrane, 7 eyes with macular hole, 5 eyes with retinal detachment, and 35 eyes with proliferative diabetic retinopathy undergoing vitrectomy for medical treatment from April 2012 to November 2013. Vitreous levels of 15 cytokines, IL-1β, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, soluble CD40L, TNFα, and IFN-γ, were measured by using multiplex bead analysis.

Results: IL-4, IL-6, IL-17A, IL-21, IL-22, IL-33, IL-33, soluble CD40L (sCD40L), IFN-γ, and TNFα were detected in the vitreous humor both of eyes with PDR and of eyes with non-diabetic retinopathy (non-DMR). However, all of these cytokines levels were higher in eyes with PDR (36.1 ± 5.46, 732.0 ± 193.9, 51.07 ± 6.67, 108.9 ± 26.7, 42.85 ± 9.28, 3.42 ± 2.15, 35.71 ± 8.57, 3.32 ± 1.69, and 20.56 ± 2.27, respectively) than eyes with non-DMR (14.37 ± 7.05, 462.7 ± 250.3, 10.72 ± 8.61, 27.02 ± 34.4, 11.41 ± 12.0, 1.63 ± 2.74, 7.15 ± 11.1, 0.74 ± 2.18 and 7.30 ± 2.93, respectively), in which there were significant differences in vitreous levels of IL-4, IL-17A, IL-22, sCD40L, and TNFα between them.

Conclusions: The present study demonstrated that Th17 cell-mediated immune responses were involved in the development of proliferative diabetic retinopathy, suggesting that activated Th17 cells might play a pivotal role in the progression.

Keywords: 490 cytokines/chemokines • 499 diabetic retinopathy • 555 immunomodulation/immunoregulation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×